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Abstract
Background
Rigorous monitoring supports progress in achieving maternal and newborn mortality and
morbidity reductions. Recent work to strengthen measurement for maternal and newborn
health highlights the existence of a large number of indicators being used for this purpose.
The definitions and data sources used to produce indicator estimates vary and challenges
exist with completeness, accuracy, transparency, and timeliness of data. The objective of
this study is to create a conceptual overview of how indicator validity is defined and under-
stood by those who develop and use maternal and newborn health indicators.
Methods
A conceptual framework of validity was developed using mixed methods. We were guided
by principles for conceptual frameworks and by a review of the literature and key maternal
and newborn health indicator guidance documents. We also conducted qualitative semi-
structured interviews with 32 key informants chosen through purposive sampling.
Results
We categorised indicator validity into three main types: criterion, convergent, and construct.
Criterion or diagnostic validity, comparing a measure with a gold standard, has
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predominantly been used to assess indicators of care coverage and content. Studies
assessing convergent validity quantify the extent to which two or more indicator measure-
ment approaches, none of which is a gold-standard, relate. Key informants considered con-
struct validity, or the accuracy of the operationalisation of a concept or phenomenon, a
critical part of the overall assessment of indicator validity.
Conclusion
Given concerns about the large number of maternal and newborn health indicators currently
in use, a more consistent understanding of validity can help guide prioritization of key indica-
tors and inform development of new indicators. All three types of validity are relevant for
evaluating the performance of maternal and newborn health indicators. We highlight the
need to establish a common language and understanding of indicator validity among the
various global and local stakeholders working within maternal and newborn health.
Introduction
Globally, the latest estimates indicate that 295,000 maternal deaths occurred in 2017, 2.5 mil-
lion newborns died in 2018, and 2.6 million stillbirths occurred in 2015. [1–3] Tackling this
burden has been prioritised in national, regional and global actions, with ambitious targets set
for maternal and newborn survival and well-being. [4, 5] A range of indicators are currently
used at global, regional, national and sub-national levels to monitor the progress toward these
goals, including the state of maternal and newborn health and well-being, as well as the health
systems and care processes thought to influence health outcomes. Various maternal and new-
born health initiatives have produced core indicator lists and a recent effort to map these vari-
ous indicators found a rapidly expanding number of indicators numbering over 140. [6] Data
sources, methods and definitions for estimating these indicators vary and change over time,
and additional challenges exist with completeness, accuracy, transparency, and timeliness of
available data.
For indicators to track progress, they must be measurable and clearly defined, accurate, reli-
able, valid, useful, relevant, accessible, specific, and time-bound. [7] The performance of indi-
cators used for global monitoring along these dimensions is of crucial concern. Within the
field of maternal and newborn health, work on measuring and improving validity of currently
used indicators and indicators under development is a key part of this agenda. [8–11] Assess-
ing the scientific robustness of indicators in the field of maternal and newborn health goes
back several decades, along with development of measurement methods. More recently, sev-
eral high-profile global efforts to identify and prioritise the most relevant maternal and new-
born health indicators for consistent and up-to-date tracking of progress have resulted in
additional research on indicator validity. [12, 13]
Given the amount of ongoing work to strengthen measurement for maternal and newborn
health, increased coordination and harmonization of efforts are essential. [14] Maternal and
newborn health are inextricably linked and it is important that measurement efforts address
both maternal and newborn health, capture stillbirths, and other perinatal outcomes. In 2015,
the World Health Organization (WHO) launched the Mother and Newborn Information for
Tracking Outcomes and Results Technical Advisory Group (MoNITOR), which functions as a
Technical Advisory body to the WHO on matters of measurement, metrics, and monitoring of
maternal and newborn health for the Departments of Maternal, Newborn, Child and
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Adolescent Health and Reproductive Health and Research. [15, 16] The purpose of MoNITOR
is to provide clear, independent, harmonized, and strategic advice for global and country
stakeholders engaged in maternal and newborn health measurement and accountability. This
paper is a result of research commissioned and chaired by the MoNITOR Secretariat to pro-
vide global guidance.
Objective
The objective of this paper is to present a range of perspectives on how validity of maternal
and newborn indicators is defined, understood, and measured by those who develop and use
these indicators. We define validity as the level of scientific robustness of an indicator with
respect to how well it captures a phenomenon or concept of interest. [17] We focus on the
overall meaning of indicator validity, that is, the extent to which an indicator correctly mea-
sures an underlying maternal and newborn health phenomenon. [7, 18]
We do not aim address the topic of maternal and newborn indicator validity exhaustively;
rather, we concentrate on identifying common conceptual and methodological themes and
provide examples of different types of validation research approaches. We focus primarily on
indicators related to the Sustainable Development Goals (SDGs), [5] the Global Strategy for
Women’s, Children’s, and Adolescents’ Health, [19] Every Newborn Action Plan, [20] and
Ending Preventable Maternal Mortality [21] and consider maternal and newborn health indi-
cator validation work in countries of all income levels. However, examples are taken mainly
from validation research in low- and middle-income country (LMIC) settings, as that is where
the double burden of maternal and newborn morbidity and mortality as well as uncertainties
regarding data quality concentrate. This framework is a part of a larger body of work led by
MoNITOR to develop implementation support tools on 1. measuring validity of maternal and
newborn health indicators; 2. prioritising indicators best suited for monitoring progress in var-
ious settings; 3. improving indicator usefulness and uptake by the various global and national
stakeholders; and 4. identifying gaps that require additional research. These implementation
support tools will also include an online tool to facilitate indicator use and interpretation.
Materials and methods
We were guided by principles for iterative development conceptual frameworks outlined by
Jabareen. [22] They propose that a conceptual framework is based on multidisciplinary bodies
of knowledge, and consist of “interlinked concepts that together provide a comprehensive
understanding”.
We iteratively moved between data collection and analysis, starting with mapping of data
sources, analysis and categorisation of selected data, identification and naming of concepts (in
light of the multidisciplinary literature on validity and reliability), and integration of concepts.
Between December 2017 and April 2019, we used three data gathering approaches to develop
this framework. We conducted interviews with key informants, a review of the published liter-
ature [23, 24], and a review of key indicator guidance documents, which were used to con-
struct a framework of typologies of validation studies and provide examples of various types of
indicator validation work. The validation phase of constructing this conceptual framework
consisted of presentations and discussion of drafts of this framework during the May 2018,
November 2018, and April 2019 meetings of MoNITOR and during several meetings with
MoNITOR’s co-chairs, whose feedback was incorporated in this document.
The full methods and results of the key informant interviews are reported in a separate
paper. [25] We used purposive sampling to identify key informants until thematic saturation
was achieved. First, AM, A-BM and LB drew up a list of potential key informants through
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discussion and with input from the MoNITOR co-chairs. The list was further expanded using
snowball methods to encompass qualitative and quantitative measurement experts on the vari-
ous types of maternal and newborn indicators (health system and input, care access and avail-
ability, quality of care and safety, coverage and outcomes, and health impact). The final sample
of 32 key informants interviewed included 22 measurement experts based in academic institu-
tions, four from funders operating in the space of maternal and newborn health, two from
United Nations agencies, two from implementing agencies, and two from data collection
organisations.
We used a semi-structured interview guide, pre-tested on the first five informants, covering
five themes: the meaning of indicator validity, methodological approaches to assessing validity,
acceptable levels of indicator validity, gaps in validation research, and recommendations for
addressing these gaps. Interviews (six in person and 25 by phone/Skype) were conducted by
LB in English between December 2017 and November 2018 and ranged between 45 and 90
minutes. Detailed notes were taken in shorthand during the interviews, and were transcribed
and expanded immediately following the interview. Several key informants sent additional
written materials (reports, unpublished manuscripts) and publications following their inter-
view. These were included in the literature review if relevant to the study. We used the the-
matic content approach to analyze the interview notes and identify themes through a coding
framework using a mix of deductive and inductive codes. No ethics approval was sought. All
key informants were asked to review their interview notes and agreed to have their anon-
ymized interview notes included in an open access data file. [26]
We reviewed the literature with a focus on identifying a range of study designs relevant to
indicator validation within the field of maternal and newborn health. We used a combination
of text and MeSH terms related to the concepts of 1. validity (validation, validity, reliability,
sensitivity, specificity, verification, concordance, area under the curve, receiver operating
curve), 2. maternal and newborn health (maternal, pregnancy, antenatal, childbirth, peripar-
tum, intrapartum, labour, newborn, neonatal, postpartum, postnatal, perinatal, obstetric, still-
birth), and 3. indicators (indicator, estimate) and searched Medline, Embase, and Global
Health databases on March 16, 2018 for English language articles published since 1990. Fur-
ther, we used key informant recommendations of publications and reports to complement the
search results. We screened the titles and abstracts of identified references (10,974 from Med-
line, 14,696 from Embase, 2,476 from Global Health, and 53 received from key informants).
We included 119 references in full-text and used these in the development of the conceptual
framework or as examples of validation studies. Last, we reviewed 12 key indicator guidance
documents relevant to maternal and newborn health. [6, 8, 27–36]
Definitions
An indicator is a quantifiable characteristic of a defined population which has a standard defi-
nition. [35, 36] We limit our consideration to indicators related to the health status and the
health care of women and newborns during pregnancy, childbirth and the postnatal period.
We aimed to synthesise the various perspectives on understanding and assessing validity of
maternal and newborn health indicators obtained from the literature and key informant inter-
views and to characterise these approaches using a common language to aid efforts to achieve
standard measurement language. To help characterize the various approaches used to assess
validity of maternal and newborn health indicators, we classified the key types of maternal and
newborn health indicators currently in use. For the purpose of this paper, we categorize indica-
tors (Fig 1) using a framework adapted from Moller and colleagues [6] into the following key
domains of maternal and newborn health indicators:
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Fig 1. Key domains of maternal and newborn health indicators.
https://doi.org/10.1371/journal.pone.0233969.g001
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1. Health system–includes human and financial resources, policies, guidelines, mechanisms,
and information flows.
2. Access to and availability of care—refers to accessibility of care to users, availability of
health facilities, services and essential supplies and equipment.
3. Care coverage—indicators of the extent to which care is used (e.g. antenatal care and new-
born care).
4. Care content and quality—includes care content (elements of care delivered as part of care
processes) and person-centeredness of care.
5. Impact–refers to the long-term effects on health status, including morbidity and mortality.
An appraisal of an indicator’s validity requires theoretical clarity about the concept that the
indicator is intended to measure, and should be done in conjunction with an assessment of its
reliability, and potentially also the feasibility of its production. Reliability, a key concept closely
related to validity, captures the extent to which results are repeatable; in other words, how well
the method is able to achieve similar measurement over repeated efforts. [36, 37] Studies in the
field of maternal and newborn indicators assessing reliability also use the terms consistency,
agreement, and concordance; studies assessing reliability of measures over time also use the
terms decay/deterioration (of recall), and repeatability.
The four scenarios of the combination of high/low criterion validity and reliability of a mea-
surement are visualised in Fig 2. The center of the bullseye represents the truth or the gold
standard against which criterion validity is assessed while the dots represent data points. [38]
As can be seen in the scenarios, consistent (reliable) indicator measurement may or may not
be accurately capturing the “truth” or gold standard, while consistently valid measurement
(hitting the bullseye) may still result in broad variations in estimates (limited reliability). The
possibility of an indicator measurement having relatively low reliability yet still being valid dif-
fers from the perspective of other social science disciplines; it is a result of a situation where
measurement is not precise on an individual level, but without systematic bias, and this pro-
duces estimates close to the truth on a population level (captured, for example, by inflation fac-
tor). [39–42]
Results
Three main types of validity of maternal and newborn health indicators were identified from
the existing literature and key informant interviews (S1 Table). These types broadly map onto
the social science definitions of criterion, convergent, and construct validity. Fig 3 shows an
example of the three types of validity in relation to one construct and two potential indicators
measuring this construct. We describe each type of indicator validity in detail, giving examples
of indicators and published studies, with a focus on approaches and measurement methods
used to assess validity.
a. Criterion validity: Assessment of criterion validity, also referred to as diagnostic validity,
examines whether the operationalization or measurement of a construct behaves as
expected. A common way to examine criterion validity is to compare a measurement with a
“gold-standard” or reference standard.
b. Convergent validity: Assessments of convergent validity examine the extent to which one
measurement is similar to (converges with) other measurements to which it should be
related, based on a common underlying construct (i.e. assessment of different methods of
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capturing the same construct). The main difference between criterion and convergent
validity is that for the second, no gold standard measurement is available, which is why new
or indirect measures are sometimes referred to as surrogate or proxy indicators. Assess-
ments of convergent validity in maternal and newborn health have compared two or more
indicators, or two or more measurement methods to estimate one indicator (Fig 3).
Fig 2. Visual representation of criterion validity and reliability of measurement.
https://doi.org/10.1371/journal.pone.0233969.g002
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c. Construct validity: An assessment of construct validity examines whether a given operaliza-
tion (through indicator definition and its measurement) accurately reflects the phenome-
non it is intended to measure. Construct validity is an umbrella term which subsumes all
other types of validity, and therefore available assessments of criterion, convergent and
other types of validity should be taken into consideration when evaluating the overall level
of construct validity of an indicator.
Criterion validity
Studies of maternal and newborn health indicators assessing criterion validity seek to under-
stand the accuracy of a method of measurement compared to a “gold” or reference standard.
Assessments of criterion validity measure the extent to which a current or proposed method of
generating an estimate of an indicator accurately reflects an objective truth. Several key infor-
mants suggested that criterion validity, meaning the comparison of a measurement method to a
gold standard, is perhaps the most commonly shared understanding of validity among the vari-
ous stakeholders in the maternal and newborn health field. However, they also acknowledged
that it captures the narrowest, most technical, aspect of indicator validity. Within maternal and
newborn health, studies of criterion validity have predominantly assessed concurrent rather
than predictive validity. The focus of criterion validity assessments has been largely on indica-
tors of care coverage and content and to some extent on impact indicators. Examples of studies
assessing criterion validity of maternal and newborn health indicators are shown in Table 1.
Many key informants noted that a substantial portion of recent work on assessing criterion
validity has focused on indicators of care coverage and content captured in household surveys
such as the Demographic Health Surveys (DHS) and Multiple Indicator Cluster Surveys
(MICS). [52, 53] Munos and colleagues discuss many considerations and elements of diagnos-
tic-style (criterion) validity studies related to assessing the validity of care coverage indicators
based on data from population-level surveys. [42] A common approach to assessing validity of
women’s recall of specific events or care content is to compare women’s recall (captured dur-
ing an exit interview or sometime later during a home visit) against a “gold standard” based on
Fig 3. Example of the three types of validity in maternal and newborn health indicators.
https://doi.org/10.1371/journal.pone.0233969.g003
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direct observations of care or, less commonly, care elements documented in a facility register
or patient record. The most important quantitative metrics used by assessments of criterion
validity are summarised in Table 2.
Table 2. Commonly used measures of criterion validity (adapted from [42, 54]).
Measure Definition, calculation, meaning
Individual-level validity
Sensitivity The percentage of individuals with the outcome/characteristic of interest
who were correctly classified as such.
Specificity The percentage of individuals without the outcome/characteristic of
interest correctly classified as such.
Percent agreement or Accuracy The percentage of individuals who were correctly classified, i.e. for
whom the outcome/characteristic of interest being measured is a match
to the gold-standard comparison.
Positive predictive value The probability that an individual who reported having an outcome/
characteristic of interest truly had it.
Negative predictive value The probability that an individual who did not report having an
outcome/characteristic of interest truly did not have it.
Area under the receiver operating
characteristic curve (AUC)
Plot of sensitivity versus 1-specificity. A value of 1 means a perfect
match, 0.5 a random guess. For binary measures, this is the average of
sensitivity and specificity.
Other, less commonly used, measures include likelihood ratio [49] and efficiency [48].
Population-level validity
Inflation factor (IF) or Test to Actual
Positive (TAP) ratio
Ratio of the population prevalence based on the measure being assessed
in comparison with the true prevalence based on the gold standard. [55]
This measure expresses the extent to which the true population
prevalence of the indicator is under- or over-estimated, given the
sensitivity and specificity of the measure under consideration and the
true population prevalence. It is possible for an indicator to show low
individual-level accuracy but good population-level accuracy.
https://doi.org/10.1371/journal.pone.0233969.t002
Table 1. Examples of studies assessing criterion validity.
Indicator domain Examples of studies (reference standard and
setting)
Care coverage Women’s self-report compared to:
• Observations during antenatal, intrapartum and
postnatal care from
˚ Hospitals in Kenya [40, 43],
˚ Health facilities in Mozambique [44].
Women’s self-report compared to:
• Medical records from medical booklets and HMIS:
China through population-based survey [45].
Coverage of maternal and newborn care interventions,
skilled provider at birth, caesarean section rate
Care content and quality Women’s self-report compared to:
• Observations of care in hospitals in Tanzania,
Bangladesh, Nepal [46]
• Medical records/facility registers in hospitals in
Tanzania, Bangladesh, Nepal [46].
Immediate initiation of breastfeeding, newborn resuscitation
Impact Women’s self-report compared to:
• Biomarkers and/or medical diagnoses as captured
in clinical notes in samples drawn from:
˚ Indonesian hospitals [47],
˚ Ghana hospital [48],
˚ A tertiary hospital in Brazil [49],
˚ Maternity hospitals in Bolivia [50].
Women’s self-report compared to:
• Clinical examination findings from a community
survey in Egypt [51].
Prevalence of maternal morbidities or obstetric
complications (e.g. haemorrhage, pre-eclampsia/eclampsia,
labour dystocia, prolapse), prevalence of severe maternal
morbidity or near miss
https://doi.org/10.1371/journal.pone.0233969.t001
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Some of the limitations of these predominantly facility-based criterion validity studies
include limited generalisability, additional assumptions required to assess the extent of bias
affecting population-level estimates, and issues with high coverage of routine care elements,
which lead to sample sizes too small to calculate specificity. In addition, maternal and newborn
health indicators based on population-level surveys have a two- to five-year recall period. Indi-
cator validity is dependent on the ability of women to recall an event, which may be affected by
length of time since the event. Only a few studies have assessed criterion validity based on
length of the recall period since pregnancy and childbirth; many report substantial issues in
the ability to ensure high follow-up rates and found some deterioration in the accuracy of
women’s recall as the length of recall period increases. [43, 44, 47, 49]
Despite the numerous metrics to statistically assess criterion validity, there is no consensus
on what thresholds indicate acceptable or good indicator validity levels. Key informants agreed
that there is no objective or recommended cut-off point for a “good” level of diagnostic validity
that could single-handedly inform a recommendation to endorse the use of an indicator. Such
endorsement would rely on crucial additional considerations, such as the intended use of the
proposed indicator, quality of the data and its source(s), and quality of the gold standard used
to assess validity. One key informant commented that “acceptable validity depends on how
much imperfection you are willing to put up with and what purpose is the information for”.
We present examples of pre-specified cut-offs provided by studies assessing validity of indi-
cators based on women’s recall (Table 3). It is important to note that most studies focus solely
on assessing validity of indicator numerators. The validity of an indicator’s denominator also
has implications for the validity of the overall indicator, but has been less commonly evaluated.
This is particularly important for indicators where the denominator is the population in need
of an intervention. Decades of work to try to define the need for caesarean section as a denom-
inator for a caesarean section rate indicator (including setting benchmark levels of caesarean
section rates for all births irrespective of need used as a denominator) have led to the conclu-
sion that the population of women in need of a caesarean section must be defined locally based
on the epidemiological profile and context. [56, 57] Similarly, ongoing work to define appro-
priate denominators of newborns in need of targeted interventions such as resuscitation face a
similar challenge since the population of newborns in need of resuscitation may vary based on
different context and settings, e.g. be higher in referral compared to primary facilities. [58]
Key informants also highlighted the recent development and use of new indicators, such as
those capturing maternal and newborn health financing, policies, and health system aspects.
For health systems indicators, the validity of indicators capturing the existence of specific poli-
cies is sometimes referred to as “verification”. Methods for such research might include a Min-
istry of Health representative reporting on policies, compared to the “gold standard” of policy
existence as a ratified document, assessed through a document review. [59] Existence of a pol-
icy, however, does not guarantee its rollout or implementation, merely its existence.
Convergent validity
The second common type of indicator validity assessment we identified in the literature com-
pares estimates from various data sources or measurement approaches seeking to measure the
same construct to understand the convergence between them (Fig 3). Studies assessing conver-
gent validity, also referred to as “triangulation" by several key informants, aim to quantify the
extent to which two or more estimates which should be related because they converge on the
same theoretical construct, are in fact related. Assessments of convergent validity are com-
monly used in situations where a “gold standard” does not exist or is infeasible to estimate. A
typical question asked in assessments of convergent validity is the extent to which a new/
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different data source or estimation method compares to an established source or method.
Studies also seek to understand the strengths and limitations, including financial feasibility, of
the measurement approaches being compared. A wide range of methods has been used to
examine the extent of agreement between distinct measurement methods and data sources
used to calculate an indicator, including whether the data is on an individual, cluster (e.g.
region, facility), or population level. Similarly to criterion validity, the cut-off point for an
acceptable level of convergent validity is also subjective. Examples of studies assessing
Table 3. Examples of pre-specified acceptable validity levels.
Source Indicator types Metric and Level
Ronsmans 1996 [54] Maternal morbidity, obstetric complications Fairly accurate if sensitivity and specificity
>80%; high specificity is very important for
rare outcomes to limit over-reporting of
actual prevalence
Liu et al. 2013 [45] Coverage and content of antenatal, delivery
and postnatal care
Sensitivity/specificity:
• Low <0.33
• Moderate 0.33–0.66
• High >0.66
AUC–overall validity “high” if AUC>0.67
(otherwise moderate/low)
Population-level bias
• Small if 0.8<TAP ratio<1.2
• Moderate 0.5<TAP ratio<1.5
• Large <0.5 TAP ratio >1.5
Stanton et al. 2013
[44]
Maternal and newborn health interventions
during peripartum period in health facilities
Acceptable if
AUC>0.60 or IF 0.75–1.25
(Suggest indicators warranting incorporation
into population-level surveys should meet
both criteria- individual and population level
validity)
Blanc et al. 2016 [40],
McCarthy et al. 2016
[43]
Quality of maternal and newborn health
care during childbirth
Individual-level accuracy measured by AUC
• High: AUC>0.7
• Moderate: 0.6<AUC<0.7
• Low: AUC<0.6
Degree of bias measured by IF
• Low 0.75<IF<1.25
• Moderate 0.5<IF<1.5
• Large IF<0.5 | IF>1.5
High overall performance: high AUC + low
IF
Reliability (decay in accuracy between
baseline taken during exit interview and at
13–15 months post delivery)–Phi coefficient
(rphi)
• Poor if <0.4, Moderate between 0.4 and 0.6;
High 0.6–0.8; > = 0.8 almost perfect
agreement.
Blanc et al. 2016 [60] Skilled birth attendant and key elements of
maternal, intrapartum, newborn and
immediate postnatal care among women
with vaginal deliveries
Benchmarks of validity:
• AUC> = 0.6
• 0.75<IF<1.25
Overall acceptable indicator performance:
both AUC and IF benchmarks met
Munos et al. [42],
Chang et al. 2018 [61]
Coverage indicators AUC�0.70
IF 0.75–1.25
(study authors acknowledge these are
arbitrary)
AUC: Area under the receiver operating characteristic curve; TAP: test to actual positive ratio; IF: inflation factor.
https://doi.org/10.1371/journal.pone.0233969.t003
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convergent validity are shown in Table 4. We did not identify studies of discriminant validity
(assessments of the extent to which an indicator is not associated with indicators or constructs
it should not be associated with).
Construct validity
One of the most important types of indicator validity highlighted in key informant interviews
was construct validity. An indicator provides a simplified way of capturing a more complex
phenomenon. Construct validity can be defined as the accuracy of the operationalisation of
such phenomenon, and thus assesses the extent to which inferences can be made from the
operationalization of an indicator to the theoretical construct which those operationalizations
were intending to reflect. [68] In other words, the question is not how valid an indicator is, but
how valid is this specific measurement of an indicator, in this place, at this time. In regard to
indicator construct validity Arnold and Khan call this process of transforming concepts into
indicators and further into survey questions the “validity of question”. [69] The purpose of an
indicator is central to assessing construct validity as well as other types of validity, [70] or, as
noted by Etches and colleagues, “[a] concept-driven selection process should result in more
methodologically sound indicators.” [71]
The importance of clearly understanding and articulating an indicator’s purpose was
highlighted in a recent paper by Radovich and colleagues that examined the indicator captur-
ing the percentage of births occurring with the assistance of a skilled birth attendant (SBA).
[72] Several respondents emphasized that the process of assessing whether an indicator is
“valid” should start with an understanding of not only the construct or phenomenon an indi-
cator intends to measure, but also for whom and why. This includes a consideration of
whether the underlying phenomenon itself is meaningful, that is, whether its purpose is impor-
tant to maternal and newborn health and clearly understood by all stakeholders (S1 Table). A
rigorous and complete assessment of construct validity must include both theoretical and
empirical approaches, ideally involving the users of indicators for decision-making in the vari-
ous global settings. [73] Yet, despite the importance attributed to construct validity by key
informants, there was comparatively little published literature within maternal and newborn
health focusing on this topic.
Some of the key indicators currently in use in the field of maternal and newborn health
were developed, or are being used, as proxies for constructs that are considered important by
Table 4. Examples of approaches to assess convergent validity.
Indicator Estimation method 1 Estimation method 2 Comparison
Stillbirth rate, neonatal
mortality rate [62]
Full history of all live births and questions on pregnancies
in the last five years resulting in non-live births
Full history of all pregnancies
and their outcomes
Crude and adjusted risk ratios
(determinants and clustering)
Maternal and perinatal
mortality [63]
Enhanced community-level surveillance system Routine data Comparison of rate/ratios
Postnatal care coverage
[64]
DHS questions MICS questions Descriptive comparison of proportions
and timing
Caesarean section rate [65] Population-based survey (DHS, MICS) Health facility records Linear regression coefficient;
confidence interval overlap
Antenatal care coverage
and content [66]
Individual-level data from clinical records weighted to
population level
Aggregate routine health
information systems reports
Simple comparisons of proportions and
95% confidence intervals
Estimates of value of aid for
RMNCAH [67]
Comparison of estimates from four initiatives: Countdown to 2015, the Institute for Health
Metrics and Evaluation, the Muskoka Initiative, and the Organisation for Economic Co-
operation and Development (OECD)
Simple differences
DHS—Demographic Health Surveys, MICS—Multiple Indicator Cluster Surveys, RMNCAH–Reproductive, maternal, newborn, child and adolescent health.
https://doi.org/10.1371/journal.pone.0233969.t004
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stakeholders but are not feasible or possible to measure simply or directly. This relates to, for
example, maternal mortality (large sample sizes required means measurement is expensive)
[74–76] and quality of care (a multi-dimensional construct requiring data on technical and
clinical levels as well as patient’s experience). [77] In particular, many key informants
highlighted the importance of recent work around indicators of care content and quality,
which concerned with the extent to which measurement methods can capture complex, multi-
faceted constructs. Examples of this type of validity research, which also include considerations
of face and content validity of measurement approaches (e.g. scales and questionnaires),
include indicators of quality of care from a woman’s perspective, [78] from a health facility
perspective [79] indicators of complex care processes (e.g. case management of pre-eclampsia),
indicators of autonomy and respectful care [80] and person-centered maternity care. [81]
Additional challenges exist with measuring quality of newborn care, starting with the data
source (newborns have limited communication and if the baby is taken out of the mother’s
sight, she cannot report accurately). [82] While this work forms a large part of the current vali-
dation research of maternal and newborn health indicators, it is not yet fully formed.
Discussion
Using mixed methods, we identified three common types of indicator validity used in the field
of maternal and newborn health, all of which have a role in evaluating the performance of indi-
cators. Key informant interviews revealed that a variety of definitions and interpretations of
indicator validity exist, highlighting the need to establish a common language and understand-
ing of indicator validity among global and local maternal and newborn health stakeholders.
We have attempted to synthesize key concepts and to present a typology of indicator validity
that characterizes the varied ways in which the concept of validity is understood and assessed
in the literature, indicator guidance documents and by a sample of maternal and newborn
health stakeholders. We suggest that those who develop, assess or recommend maternal and
newborn health indicators clarify their understanding of the various types of validity of studied
or recommended indicators.
Despite the importance of construct validity highlighted in key informants’ responses, we
identified a gap in the literature and indicator guidance documents in explicitly describing and
evaluating the underlying phenomena which various maternal and newborn health indicators
seek to measure, and an absence of studies of construct validity in general. For example, is the
SBA indicator intended to measure an enabling childbirth health care environment, coverage
of good quality childbirth care, minimum safety levels during childbirth, to be a proxy for
maternal mortality, or relate to multiple constructs? Conceptual understanding of the underly-
ing phenomena that specific indicators are intended to measure may vary across stakeholders
using the indicators and may change over time, but are rarely made explicit.
There is a predominance of validation studies on the narrowest conceptualisation of valid-
ity–criterion validity–but the larger issue of the construct and its meaning for progress in
maternal and newborn health is rarely addressed. Once developed, used and measured with a
high uptake for many years, maternal and newborn health indicators tend to remain in use for
decades. However, the constructs being measured by such indicators are often unclear or may
evolve in importance over time. We also highlight a view shared by many key informants that
an indicator’s performance on assessment of criterion validity should not be the sole determi-
nant of its use for monitoring and decision-making; its measurement parameters need to be
“good enough” for the purpose at a given time and place. [25] One such aim could include
generating aspirational indicator estimates for the purpose of improving quality of data or
measurement methods for the future. [8]
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There is a growing concern with the large number of maternal and newborn health indica-
tors used across several initiatives, including the variation in indicator definitions and the
resources required to produce such indicators. [6] A more consistent understanding of indica-
tor validity could help guide the prioritization, development and testing of more robust mater-
nal and newborn health indicators. [14] Improved global coordination among stakeholders
conducting or supporting validation studies is needed to avoid duplication of efforts. Further,
it is crucial to consider the perspectives of country-level stakeholders in prioritising which
types of validation matter most for which indicators and which types of indicators should be
validated first and where. The development of guidance and criteria for assessing common
types of indicator validity, linked to an action plan to prioritize indicators for validation, could
help improve such coordination. Coordinated research to assess validity of a smaller number
of locally relevant core indicators that seek to measure important constructs could help accel-
erate action to improve maternal and newborn health. In parallel, it is also vital to coordinate
assessment of indicator validity with assessment of other important attributes of indicators,
including feasibility and reliability. [83] Studies which describe elements of clarity, feasibility
and acceptability of data collection tools, [84–87] such as those employed in qualitative studies
and cognitive interviewing, [84] are complementary to other assessments of validity.
Limitations
We used a literature review and key informant interviews to explore the field of indicator vali-
dation research in maternal and newborn health indicators. We conducted a comprehensive
review of the literature published in English since 1990 to identify key themes and provide
examples and acknowledge that our review may have missed relevant publications in lan-
guages other than English. We also acknowledge that while the key informants included mea-
surement experts and authors of many of the recently conducted validation studies on
maternal and newborn health indicators within the maternal and newborn health field, our
sample of key informants included only English-speaking respondents working predominantly
at the global level and did not include many country-level experts and stakeholders. We did
not aim to summarize the findings of all validation studies for individual indicators; however,
such systematic reviews and meta-analyses could be a useful next step for summarising the
available evidence.
While we were informed by “multidisciplinary bodies of knowledge” which are needed for
high quality conceptual frameworks, it is important to recognise that the issues surrounding
validity of population health indicators are somewhat different from those of tools or question-
naires as elaborated in other disciplines, particularly psychology. [88] Some distinct types of
validity used in these fields are not relevant to our topic and the definitions of validity we pro-
pose in this framework do not completely overlap with definitions used in other disciplines.
Conclusion
Indicator validation is a part of a continuous process of building and synthesising evidence on
indicator performance. We found that in the maternal and newborn health literature and
among measurement experts, the term validity is used broadly to capture a variety of indicator
performance assessments. Some of the current challenges related to harmonization and coor-
dination of maternal and newborn health indicators stem from a heterogeneity of definitions
of indicator validity, often by stakeholders from various disciplinary backgrounds. We recom-
mend that the language used to describe validation research should be more precise as to the
specific type(s) of validation assessed and the related findings (e.g. an indicator described as
“valid” or “validated” should be nuanced and time- and context-specific).
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In addition to the three most common types of maternal and newborn health indicator
validity identified, we highlight the fact that any appraisal of an indicator’s validity requires
clarity about the construct that the indicator is intending to measure. We therefore recom-
mend that future initiatives to coordinate indicator validity research focus on important
underlying constructs rather than individual indicators (which represent the operationaliza-
tion of constructs). This approach can help align stakeholders to develop a clear understanding
of how best to measure important constructs, including agreement on “how not to measure” a
construct for which “valid” indicators may not yet have been developed and tested.
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